{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:24:27Z","timestamp":1762251867952},"reference-count":28,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"vor","delay-in-days":354,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.015","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T18:01:48Z","timestamp":1345399308000},"page":"6421-6426","source":"Crossref","is-referenced-by-count":8,"title":["Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas?"],"prefix":"10.1016","volume":"30","author":[{"given":"Renata Santos","family":"Tourinho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilson Jos\u00e9","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciane Almeida","family":"Amado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia Melo","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita Coimbra Motta","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Salete","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.08.015_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0264-410X(99)00466-1","article-title":"Hepatitis A shifting epidemiology in Latin America","volume":"18","author":"Tanaka","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.015_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S0074-02762006000200001","article-title":"Epidemiological pattern and mortality rates for hepatitis A in Brazil: 1980\u20132002 \u2013 a review","volume":"101","author":"Vitral","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"May","key":"10.1016\/j.vaccine.2012.08.015_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2893.2003.00422.x","article-title":"Who should receive hepatitis A vaccine","volume":"10","author":"Arankalle","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0074-02761998000100001","article-title":"Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors","volume":"93","author":"Vitral","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jviromet.2004.09.001","article-title":"Detection of HCV antibodies in oral fluid","volume":"122","author":"De Cock","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0030","first-page":"245","article-title":"Detection of viral antibodies in saliva specimens as an alternative to serum","volume":"27","author":"Parry","year":"1989","journal-title":"J Clin Chem Clin Biochem"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.015_bib0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/JCM.35.1.98-101.1997","article-title":"New, ultrasensitive enzyme immunoassay for detecting vaccine and disease-induced hepatitis A virus-specific immunoglobulin G in saliva","volume":"35","author":"Ochnio","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.015_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652000000400004","article-title":"Detection of hepatitis A antibodies by ELISA using saliva as clinical samples","volume":"42","author":"Oba","year":"2000","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0045","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/aje\/kwh107","article-title":"A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales","volume":"159","author":"Morris-Cunnington","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0074-02762006000200006","article-title":"Detection of hepatitis A, B and C virus-specific antibodies using oral fluid for epidemiological studies","volume":"101","author":"Amado","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jmv.1890400106","article-title":"Hepatitis A antibody titers after infection and immunization: implication for passive and active immunization","volume":"40","author":"Zaaijer","year":"1993","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.015_bib0060","first-page":"417","article-title":"Passage of intact IgG from plasma to the oral cavity via crevicular fluid","volume":"34","author":"Challacombe","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0065","series-title":"Oral immunity of oral disease","author":"Roitt","year":"1983"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1749-6632.1993.tb18355.x","article-title":"Simple and reliable salivary test for HIV and hepatitis A and B virus diagnosis and surveillance","volume":"694","author":"Parry","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2012.08.015_bib0075","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0035-9203(98)90811-2","article-title":"An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community","volume":"92","author":"Nokes","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0080","series-title":"Practical statistics for medical research","author":"Altman","year":"1991"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.015_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00190267","article-title":"Sensitivity of HIV antibody detection in saliva","volume":"182","author":"Stark","year":"1993","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"May (55) (RR-7)","key":"10.1016\/j.vaccine.2012.08.015_bib0090","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"19","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"July (25)","key":"10.1016\/j.vaccine.2012.08.015_bib0095","first-page":"776","article-title":"Hepatitis A vaccination coverage among U.S. children aged 12\u201323 months \u2013 immunization information system sentinel sites, 2006\u20132009","volume":"59","author":"Centers for Disease Control Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0100","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/BF01691223","article-title":"Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid","volume":"15","author":"McIntyre","year":"1996","journal-title":"Eur J Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jmv.10463","article-title":"Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots","volume":"71","author":"Judd","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jviromet.2011.01.014","article-title":"Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay","volume":"173","author":"Tourinho","year":"2011","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.015_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10654-007-9105-6","article-title":"A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium","volume":"22","author":"Quoilin","year":"2007","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.015_bib0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-302X.2008.00500.x","article-title":"Efficiency of oral fluid collection devices in extracting antibodies","volume":"24","author":"Chang","year":"2009","journal-title":"Oral Microbiol Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.08.015_bib0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00002030-199209000-00007","article-title":"Detection of HIV antibodies in saliva as a tool for epidemiological studies","volume":"6","author":"van den Akker","year":"1992","journal-title":"AIDS"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.08.015_bib0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jpba.2008.01.033","article-title":"Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs","volume":"47","author":"Gr\u00f6schl","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2012.08.015_bib0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0033-3506(01)00444-9","article-title":"A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children","volume":"115","author":"Vyse","year":"2001","journal-title":"Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2012.08.015_bib0140","first-page":"588","article-title":"Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia","volume":"79","author":"Nokes","year":"2001","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12011942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12011942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T18:13:46Z","timestamp":1594577626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12011942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":28,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X12011942"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}